1

Results based on the full FinnGen cohort of 500,000 participants released!

Study cohort

FinnGen has collected and correlated genome and longitudinal health data of more than 500 000 Finns, which is almost 10% of the Finnish population.

Participation

The FinnGen study utilises samples collected by a nationwide network of Finnish biobanks. The study is based on combining genome information with digital health care data from national health registries.

Everybody benefits

The genome data produced during the project will be owned by the Finnish biobanks, and remain available for researcher purposes. The medical breakthroughs that arise from the project will eventually benefit health care systems and patients globally.

Collaboration is the key

The collaborative nature of the FinnGen research project is exceptional compared to many other studies. The study involves all the same actors as drug development. With this open cooperation, we hope to speed up the emergence of new innovations.

Data freeze 12 results and summary statistics now available!

Results can be browsed online using the FinnGen web browser and the summary statistics downloaded
This data freeze consists of >500,000 individuals, more than 21.3 M variants and 2,500 health endpoints. To get more information about how to access the results and summary statistics, please follow this link:
Northern lights.

New accessible and engaging FinnGen communication resource available!

Scroll through the website to learn about the FinnGen project, its goals, processes and its impact in Finland and around the world.
Can you imagine what genetic diversity looks like in large populations or visualise where genes are located on chromosomes in relation to each other? We teamed up with Aalto University to produce a resource that uses data visualisation to tell the FinnGen story to a wider audience.
Screenshots from the scrollytelling website.

News

Join us on September 4, 2025, for an interactive event to explore the future of the Finnish health data ecosystem, current opportunities in research collaboration and the potential to accelerate R&D between the public and private sectors.
An international study on long Covid, led by the University of Helsinki and drawing on data from more than one million individuals, has pinpointed a genetic factor that predisposes people to prolonged post-coronavirus symptoms such as debilitating fatigue, persistent cough, “brain fog” and blood pressure fluctuations.

FinnGen brings together the nation-wide network of Finnish biobanks.

Every Finn can be a part of the FinnGen study by giving a biobank consent.
Samples available
629 000
Samples needed by 2023: 520 000
Current data freeze
520 210
combined genotype and health registry data